Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali

Abstract Background In 2006, the National Malaria Control Program in Mali recommended artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria. Since the introduction of artemisinin-based combination therapy, few reports are available on the level of resistance of...

Full description

Saved in:
Bibliographic Details
Main Authors: Karim Traoré (Author), Seidina A. S. Diakité (Author), Sekou Bah (Author), Drissa S. Konaté (Author), Djeneba Dabitao (Author), Ibrahim Sanogo (Author), Modibo Sangaré (Author), Souleymane Dama (Author), Bourama Keita (Author), Mory Doumbouya (Author), Merepen A. Guindo (Author), Seydou Doumbia (Author), Mahamadou Diakité (Author)
Format: Book
Published: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_8ba7142356c048e289f3a19dc43e0a01
042 |a dc 
100 1 0 |a Karim Traoré  |e author 
700 1 0 |a Seidina A. S. Diakité  |e author 
700 1 0 |a Sekou Bah  |e author 
700 1 0 |a Drissa S. Konaté  |e author 
700 1 0 |a Djeneba Dabitao  |e author 
700 1 0 |a Ibrahim Sanogo  |e author 
700 1 0 |a Modibo Sangaré  |e author 
700 1 0 |a Souleymane Dama  |e author 
700 1 0 |a Bourama Keita  |e author 
700 1 0 |a Mory Doumbouya  |e author 
700 1 0 |a Merepen A. Guindo  |e author 
700 1 0 |a Seydou Doumbia  |e author 
700 1 0 |a Mahamadou Diakité  |e author 
245 0 0 |a Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali 
260 |b Adis, Springer Healthcare,   |c 2020-06-01T00:00:00Z. 
500 |a 10.1007/s40268-020-00313-4 
500 |a 1174-5886 
500 |a 1179-6901 
520 |a Abstract Background In 2006, the National Malaria Control Program in Mali recommended artemisinin-based combination therapy as the first-line treatment for uncomplicated malaria. Since the introduction of artemisinin-based combination therapy, few reports are available on the level of resistance of Plasmodium falciparum to the most common anti-malarial drugs in Mali. Methods From 2016 to 2017, we assessed the ex-vivo drug sensitivity of P. falciparum isolates in Kéniéroba, a village located in a rural area of southern Mali. We collected P. falciparum isolates from malaria-infected children living in Kéniéroba. The isolates were tested for ex-vivo sensitivity to commonly used anti-malarial drugs, namely chloroquine, quinine, amodiaquine, mefloquine, lumefantrine, dihydroartermisinin, and piperaquine. We used the 50% inhibitory concentration determination method, which is based on the incorporation of SYBR® Green into the parasite's genetic material. Results Plasmodium falciparum isolates were found to have a reduced ex-vivo sensitivity to quinine (25.7%), chloroquine (12.2%), amodiaquine (2.7%), and mefloquine (1.3%). In contrast, the isolates were 100% sensitive to lumefantrine, dihydroartermisinin, and piperaquine. A statistically significant correlation was found between 50% inhibitory concentration values of quinine and amodiaquine (r = 0.80; p < 0.0001). Conclusions Plasmodium falciparum isolates were highly sensitive to dihydroartermisinin, lumefantrine, and piperaquine and less sensitive to amodiaquine (n = 2), mefloquine (n = 1), and quinine (n = 19). Therefore, our data support the previously reported increasing trend in chloroquine sensitivity in Mali. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Drugs in R&D, Vol 20, Iss 3, Pp 249-255 (2020) 
787 0 |n https://doi.org/10.1007/s40268-020-00313-4 
787 0 |n https://doaj.org/toc/1174-5886 
787 0 |n https://doaj.org/toc/1179-6901 
856 4 1 |u https://doaj.org/article/8ba7142356c048e289f3a19dc43e0a01  |z Connect to this object online.